Jean-Pierre Garnier1. Show Affiliations » 1. GlaxoSmithKline.
Abstract
Mesh: See more » AgedCost-Benefit AnalysisDeveloping CountriesDrug CostsDrug Industry/economicsDrug Industry/organization & administrationDrugs, GenericHealth Care SectorHumansInsurance, Pharmaceutical ServicesMedicareResearchUnited StatesVaccines
Substances: See more » Drugs, GenericVaccines
Year: 2003 PMID: 12889759 DOI: 10.1377/hlthaff.22.4.119
Source DB: PubMed Journal: Health Aff (Millwood) ISSN: 0278-2715 Impact factor: 6.301